Central effects of intravenously (i.v.)-administered iohexol were compared with those of iopamidol in a series of tests. Mannitol was used as a reference. As assayed by the primary screening test based on Irwin's method, i.v. administration of mannitol resulted in a score of 0 in ddY mice and a score of 0.6 in ICR mice in the startle response. These results were not different from the data of both iohexol and iopamidol. Iopamidol at a dose of 1750 mgI/kg produced an inhibitory effect on the spontaneous locomotor activity. Iohexol at a dose of 7000 mgI/kg potentiated the duration of thiopental-induced narcosis. Hypothermia was caused by high doses of both iohexol and iopamidol. Electric stimulus increased the mortality of mice pretreated with high doses of iohexol and iopamidol. Both drugs had no notable activities in the anticonvulsant, electroencephalic, muscle relaxant and antinociceptive tests. These results indicate that both iohexol and iopamidol do not necessarily possess a similar pharmacological action. Judging from the LD50 of approximately 15000 mgI/kg for both drugs, they seem unlikely to have a specific pharmacological action on the central nervous system.

Download full-text PDF

Source
http://dx.doi.org/10.1254/fpj.101.4_269DOI Listing

Publication Analysis

Top Keywords

iohexol iopamidol
20
high doses
8
doses iohexol
8
pharmacological action
8
iohexol
7
iopamidol
7
[central effects
4
effects iohexol
4
iopamidol non-ionic
4
non-ionic contrast
4

Similar Publications

Article Synopsis
  • This study analyzed the FDA Adverse Event Reporting System (FAERS) database to investigate negative reactions associated with iodinated contrast media (ICM) over nearly two decades (2004-2023).
  • It focused on five types of ICMs, assessing 11 million reports to identify the nature and strength of adverse events linked to these drugs using various statistical methods.
  • Findings indicated significant adverse drug reactions primarily related to respiratory and immune disorders, with specific concerns for throat irritation among females linked to ioversol and iopromide.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates a new algorithm designed for personalized contrast injection during liver CT scans to enhance imaging quality while ensuring patient safety.
  • Data was collected from 384 adult patients undergoing abdominal CT for cancer staging or follow-up, utilizing a web interface to customize the contrast injection based on individual characteristics.
  • Results showed that the algorithm consistently achieved liver enhancement centered at 50 HU across different patient demographics, reinforcing its potential to improve diagnostic accuracy in personalized medicine.
View Article and Find Full Text PDF

Aims: To prospectively determine whether extrinsic warming of the low-osmolality CT contrast media (Iohexol 350, Iodixanol 320, Iopromide 300, and Iopamidol 300) to 37°C prior to intravenous administration affects extravasation and allergic-like reaction rates.

Materials And Methods: This large scale prospective case control study of adverse events included all the patients between the age group of 15-80 years undergoing routine contrast-enhanced computed tomographic (CECT) examinations from April 2018 to March 2020 at our institute. Ex vivo experiments were also performed to demonstrate change in contrast viscosity and fluid dynamics in relation to temperature.

View Article and Find Full Text PDF

Skin Test Reactivity Patterns in Patients Allergic to Iodinated Contrast Media: A Refined View.

J Allergy Clin Immunol Pract

March 2024

Institut Desbrest d'Épidémiologie et de Santé Publique, UMR UA11, University of Montpellier-INSERM, Montpellier, France; Department of Pulmonology, Division of Allergy, Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France.

Background: Two-dimensional (2D) classifications of iodinated contrast media (ICM) are insufficient to explain the observed skin test (ST) reactivity patterns in patients with drug hypersensitivity reactions (DHRs) to ICM.

Objective: To refine the current view on allergic DHRs to ICM by analyzing ST reactivity patterns in patients with previous reactions to ICM.

Methods: Patients with a history of DHR to ICM and positive STs, who presented at the University Hospital of Montpellier between 2004 and 2022, were included in the study.

View Article and Find Full Text PDF

Purpose: This study aimed to evaluate the Pharmacovigilance (PV) and severity of hypersensitivity reactions induced by non-ionic Iodinated Contrast Media (ICM) in the radiology diagnosis reported to the United States Food and Drug Administration Adverse Event Reporting System (FAERS).

Methods: We retrospectively reviewed the reports of ICM-induced hypersensitivity reactions submitted to the FAERS database between January 2015 and January 2023 and conducted a disproportionality analysis. The seven most common non-ionic ICM, including iohexol, iopamidol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol, were chiefly analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!